Unusual Lifespan of Edwards' Syndrome in COVID-19 Era

被引:0
|
作者
Suryaningrat, Filla Reviyani [1 ]
Hudayari, Devatri [1 ]
Amalda, Natasha [1 ]
Mardhiya, Wan Rita [1 ]
Kadi, Fiva Aprilia [1 ]
Primadi, Aris [1 ]
Yuniati, Tetty [1 ]
机构
[1] Univ Padjadjaran, Dr Hasan Sadikin Gen Hosp Bandung, Fac Med, Neonatol Div,Dept Child Hlth, Bandung, Indonesia
来源
MAJALAH KEDOKTERAN BANDUNG | 2024年 / 56卷 / 03期
关键词
Covid; 19; full trisomy; survival; trisomy; 18;
D O I
10.15395/mkb.v56.3230
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Edwards' syndrome is caused by an extra chromosome on the 18th chromosome. Patients with this diagnosis have median survival of only 3-14.5 days, with the majority of infants with full trisomy 18 type die before or shortly after they are born. There is only supportive treatment available for Edwards' syndrome. During the COVID-19 pandemic, providing health services was challenging, leading to less than optimum treatments added by patients' reluctance to visit healthcare facilities due to the fear of COVID-19 transmission. This case study presented an infant with Edwards' syndrome with major malformation. The patient had several organ problems, was admitted to the NICU, and continued with home care for monitoring for 6 months. Patient then died at 9 months of age. Maintaining the best quality of life for this patient was very challenging for parents and healthcare providers. Since the management for this type of sydnome is more palliative, good education, information, and psychosocial supports for the parents are needed to prepare them with the worst conditions, which was especially more challenging during the COVID-19 pandemic.
引用
收藏
页码:228 / 234
页数:7
相关论文
共 50 条
  • [31] Loneliness in the Era of COVID-19
    Miller, Eric D.
    FRONTIERS IN PSYCHOLOGY, 2020, 11
  • [32] PTSD in the COVID-19 Era
    Chamaa, Farah
    Bahmad, Hisham F.
    Darwish, Batoul
    Kobeissi, Jana M.
    Hoballah, Malak
    Nassif, Sibell Bou
    Ghandour, Yara
    Saliba, Jean-Paul
    Lawand, Nada
    Abou-Kheir, Wassim
    CURRENT NEUROPHARMACOLOGY, 2021, 19 (12) : 2164 - 2179
  • [33] Telemedicine in the Era of COVID-19
    Portnoy, Jay
    Waller, Morgan
    Elliott, Tania
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (05): : 1489 - 1491
  • [34] Adapting in the COVID-19 Era
    Papathanakos, Georgios
    Andrianopoulos, Ioannis
    Papathanasiou, Athanasios
    Lepida, Dimitra
    Koulouras, Vasilios
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2020, 24 (12) : 1286 - 1287
  • [35] Influenza in the COVID-19 Era
    Solomon, Daniel A.
    Sherman, Amy C.
    Kanjilal, Sanjat
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (13): : 1342 - 1343
  • [36] Asthma in the era of COVID-19
    Assaf, Sara
    Stenberg, Henning
    Jesenak, Milos
    Tarasevych, Svitlana P.
    Hanania, Nicola A.
    Diamant, Zuzana
    RESPIRATORY MEDICINE, 2023, 218
  • [37] Misinformation in the COVID-19 era
    Toth, Gabor
    Spiotta, Alejandro M.
    Hirsch, Joshua A.
    Fiorella, David
    JOURNAL OF NEUROINTERVENTIONAL SURGERY, 2020, 12 (09) : 829 - 830
  • [38] Universities in the COVID-19 Era
    Journal of the Institute of Electrical Engineers of Japan, 2021, 141 (12):
  • [39] Radiotherapy in the era of COVID-19
    Lancia, Andrea
    Bonzano, Elisabetta
    Bottero, Marta
    Camici, Marta
    Catellani, Francesco
    Ingrosso, Gianluca
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (08) : 625 - 627
  • [40] Miscommunication in the COVID-19 Era
    Garcia, Gerardo M.
    Haboud, Marleen
    Howard, Rosaleen
    Manresa, Antonia
    Zurita, Julieta
    BULLETIN OF LATIN AMERICAN RESEARCH, 2020, 39 : 39 - 46